Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 3, 2015Blood

Five-Year Survival Data Demonstrating Durable Responses from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRobert ChenAGAjay K. GopalSSScott E. Smith

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2015) studied this question.

synapsesocial.com/papers/6a79e49d4c448619ca0ded02https://doi.org/10.1182/blood.v126.23.2736.2736
View Full Paper
Ask AI
Bookmark
Share